{
  "paper_metadata": {
    "pmid": "37486082",
    "title": "Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN\u2010MP Study",
    "extraction_summary": "Extracted information on the TTR gene variant V122I, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 18,
        "demographics": "Older Black individuals, age \u226560 years",
        "phenotype": "Heart failure, with some cases of ATTR-CM"
      },
      "penetrance_data": {
        "total_carriers_observed": 18,
        "affected_count": 7,
        "unaffected_count": 11,
        "uncertain_count": null,
        "penetrance_percentage": 39.0,
        "age_dependent_penetrance": [
          {
            "age_range": "<75 years",
            "penetrance_percentage": 20.0,
            "carriers_in_range": 10,
            "affected_in_range": 2
          },
          {
            "age_range": "\u226575 years",
            "penetrance_percentage": 63.0,
            "carriers_in_range": 8,
            "affected_in_range": 5
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 82,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTR-CM",
          "evidence_sentence": "The median age of those with penetrant ATTR\u2010CM was 82\u2009years."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 66,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "unaffected",
          "phenotype_details": "No ATTR-CM",
          "evidence_sentence": "The median age for carriers without penetrant ATTR\u2010CM was 66\u2009years."
        }
      ],
      "functional_data": {
        "summary": "V122I carriers with ATTR-CM showed more advanced heart failure than those without.",
        "assays": [
          "echocardiographic parameters",
          "biochemical assays"
        ]
      },
      "segregation_data": "Does not segregate with disease in families as it is a population variant.",
      "population_frequency": "6.5% in the studied cohort",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study emphasizes that genotype alone is insufficient for diagnosis.",
      "key_quotes": [
        "The phenotypic penetrance of V122I was 39% (95% CI, 17\u201364).",
        "Among older Black individuals with HF and increased left ventricular wall thickness, of those with V122I, the phenotypic penetrance of ATTR\u2010CM was 39%."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variant V122I was successfully extracted."
  }
}